These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9480274)

  • 1. [New nifedipine preparation makes single daily dose possible].
    Fortschr Med; 1997 Nov; 115(33):following 54. PubMed ID: 9480274
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrections to the nifedipine meta-analysis.
    Furberg CD; Psaty BM
    Circulation; 1996 Apr; 93(7):1475-6. PubMed ID: 8641044
    [No Abstract]   [Full Text] [Related]  

  • 4. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 5. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of calcium antagonists (sublingually) in the treatment of hypertensive crises].
    Shcherban' NN; Pakhomova SP; Kalenskiĭ VKh; Podstavnaia LI
    Klin Med (Mosk); 1988 Apr; 66(4):37-9. PubMed ID: 3398448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 10. Omission of drug dose information.
    Hollenberg NK
    Arch Intern Med; 2006 Feb; 166(3):368; author reply 368-9. PubMed ID: 16476880
    [No Abstract]   [Full Text] [Related]  

  • 11. [Depot calcium antagonist. General practice study confirms good tolerance].
    MMW Fortschr Med; 2003 Jan; 145(5):56. PubMed ID: 12619222
    [No Abstract]   [Full Text] [Related]  

  • 12. [The hemodynamic effects of lomir and adalat in patients with postoperative arterial hypertension].
    Eremenko AA; Ziuliaeva TP; Bozh'eva LV; Borisov RIu
    Anesteziol Reanimatol; 1999; (5):63-6. PubMed ID: 10560156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of use of immediate-release formulations of calcium channel blockers as antihypertensive monotherapy by primary care physicians: multicentric study from Bahrain.
    Sequeira RP; Jassim Al Khaja KA; Mathur VS
    J Postgrad Med; 2002; 48(3):172-5. PubMed ID: 12432188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 18. Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment.
    Paulis L; Lísková S; Pintérová M; Dobesová Z; Kunes J; Zicha J
    Acta Physiol (Oxf); 2007 Dec; 191(4):255-66. PubMed ID: 17680837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 20. [When hypertension becomes an emergency case: lower the blood pressure, but slowly!].
    Stiefelhagen P
    MMW Fortschr Med; 2003 May; 145(22):10. PubMed ID: 12866264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.